Cite
HARVARD Citation
Jiang, X. et al. (n.d.). Radium-223 therapy in symptomatic metastatic castrate resistant prostate cancer (mCRPC) – sequential use post-abiraterone/prednisolone. Clinical oncology. pp. e10-e11. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jiang, X. et al. (n.d.). Radium-223 therapy in symptomatic metastatic castrate resistant prostate cancer (mCRPC) – sequential use post-abiraterone/prednisolone. Clinical oncology. pp. e10-e11. [Online].